Delivery Order SPE2DB24D2100-SPE2DB25FBBPT

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $16,553.85 fixed-price contract is for the supply of Injectafer 750 mg/15 ml vials, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Injectafer 750 mg/15 ml vials. The contract has a total ceiling value of $26,366.65 and an ultimate completion date of May 20, 2022. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,610.13, is for the supply of INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 3, 2025. This Delivery Order contract is part of a larger Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $11,001.13 award is for the supply of Injectafer 750 mg/15 ml vials, a specialty pharmaceutical product, with a completion date of March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Injectafer 750 mg/15 ml vials. The contract has a firm fixed price of $9,024.42 and an ultimate completion date of August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation, to supply Injectafer 750 mg/15 ml vials. The $5,490.25 contract has a completion date of January 30, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025 to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Injectafer 750 mg/15 ml vials, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a total ceiling value of $25,894.85 and a performance period through March 12, 2024. No set-aside designation was used...
This is a delivery order issued under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp's Corporate Office Division. The $35,674.09 firm fixed price contract is for the delivery of Injectafer 750 mg/15 ml vials. The IDC is valued at up to $999,999,999 and enables DLA Troop Support Medical to efficiently procure a comprehensive range of critical pharmaceutical and medical supplies from AmerisourceBergen to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,983.07 firm-fixed-price delivery order is for the injectable medication Injectafer 750 mg/15 ml vial. The contract has an ultimate completion date of January 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $17,739.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of 4,564,205,201 INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product, with a period of performance through April 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBPT
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,632.25, is for the supply of Injectafer 750 mg/15 ml vials to support federal healthcare programs. AmerisourceBergen holds a larger, $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This specific delivery order contract does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of January 8, 2025.

Generated 4/8/25, 9:55 AM